Exon 14 Deleted MET Receptor as a New Biomarker and Target in CancersAlexis B. Cortot, David Tulasne|JNCI Journal of the National Cancer Institute|2016Cited by 121
Thirty Years of Research on Met Receptor to Move a Biomarker from Bench to BedsideAlessandro Furlan, David Tulasne|Cancer Research|2014Cited by 68
ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's DiseaseFlorent Letronne, Jean‐Charles Lambert, Amandine Flaig et al.|EBioMedicine|2016Cited by 52
Caspase-generated fragment of the Met receptor favors apoptosis via the intrinsic pathway independently of its tyrosine kinase activityJ Lefèbvre, David Tulasne|Cell Death and Disease|2013Cited by 36
Transforming properties of <scp>MET</scp> receptor exon 14 skipping can be recapitulated by loss of the <scp>CBL</scp> ubiquitin ligase binding siteMarie Fernandes, David Tulasne|FEBS Letters|2023Cited by 18